| Pretraživanje | Osvježi |
|
Datamonitor HC
@Datamonitor_HC
|
2 h |
|
The 2019 American Society of #Hematology (#ASH2019) was held in December in Orlando & again CAR-T #therapies & #bispecific #antibodies were hot topics. Find out more in our report extract here bit.ly/37Ccp4V pic.twitter.com/nxl05uRzo2
|
||
|
||
|
The Jackson Laboratory
@jacksonlab
|
12 h |
|
JAX's @TrowbridgeLab had a phenomenal showing at #ASH2019! Multiple trainees gave oral presentations on the aging bone marrow microenvironment and @Jennifer_Abby presented in the plenary session 💯:
jax.org/research-and-f… pic.twitter.com/LVfFjhT16F
|
||
|
||
|
EMJ Reviews
@EMJReviews
|
5. velj |
|
Our latest hematology journal contains a review of the 61st American Society of #Hematology (ASH) Annual Meeting and Exposition. Be sure to read it today: bit.ly/37LCT3N
#ASH2019 pic.twitter.com/cRtnmqEYux
|
||
|
||
|
Medidata
@Medidata
|
4. velj |
|
#News: Watch as our @Bryantific talks about his presentation from #ASH2019 w/ @gohealio re the use of synthetic control arms in #clinicaltrials + the success his team had in replicating a control group using a synthetic approach in multiple myeloma study: bit.ly/2Q2Ch23 pic.twitter.com/cFhglmZh92
|
||
|
||
|
Biomedtracker
@Biomedtracker
|
4. velj |
|
Did you miss out on #ASH2019? Our report extract provides an overview of the meeting's findings from early #clinical results to updated results from key #clinicaltrials. Download yours here bit.ly/2S0xcbE pic.twitter.com/MH7KAD4JsH
|
||
|
||
|
Patients Rising
@patientsrising
|
3. velj |
|
At the 2019 American Society for Hematology conference there was a focus on improving patient access to clinical trials, care and innovation. #ASH2019
bit.ly/36QzMqh
|
||
|
|
||
|
Health Radio Online
@HealthProRadio
|
3. velj |
|
Chronic Lymphocytic Leukemia (CLL)
Read more: bit.ly/2tjpbWW
#CLL #ChronicLymphocyticLeukemia #ASH2019 pic.twitter.com/6wfCTJ064y
|
||
|
||
|
Northstream Global Partners
@NorthstreamGlo1
|
31. sij |
|
The future of treating chronic lymphocytic leukemia looks pretty promising. Report from CLL at ASH. @MedscapeOnc @Medscape #ASH2019 #leukemia
medscape.com/recap/921620?c…
|
||
|
|
||
|
Pharma Intelligence
@Pharma_Intell
|
31. sij |
|
Get expert analysis of the biggest news to come out of #ASH2019. Find out more in our report extract here bit.ly/36BPvck pic.twitter.com/CzwZas4trm
|
||
|
||
|
Peter van Galen
@vangalenlab
|
15. sij |
|
So after #ASH2019 I made an appointment with the optometrist only to realize my vision is perfect. You all need to increase your slides’ font size and axis labels! 👓❌
|
||
|
|
||
|
إبْرَاهِيْم المحْمَادِي I. Almahmadi
@mahmadi_i
|
11. pro |
|
العلاج الجيني لمرضى #الأنيميا_المنجلية يحرز تقدما كبيرا، دراسة تستهدف الجين المتحكم في الهيموجلوبين الجنيني HbF الذي يسمى BCL11A حيث يتم تعطيل هذا الجين لإعادة تنشيط الهيموجلوبين الجنيني HbF والذي سيؤدي لارتفاع الهيموجلوبين وتخفيف الأعراض المصاحبة للمرض.
#ASH2019 pic.twitter.com/ECIIoYvTQS
|
||
|
||
|
Louise Purton
@purton_louise
|
10. pro |
|
A wonderful speech from Emmanuelle Passegue, winner of the William Dameshek Prize #ASH2019. Also shown celebrating last night with another of our Haematology #WomeninSTEMM superstars, @TrowbridgeLab (who has also had a very successful ASH!). Proud to call these 2 friends! pic.twitter.com/QZ0xZzxdAE
|
||
|
||
|
Joshua Zeidner
@LeukDocJZ
|
10. pro |
|
It is rare to witness true practice changing presentations at ASH- oral Azacitidine improves OS and RFS in older AML pts in CR/CRi after intensive induction and consolidation. Favorable-risk was excluded however. Congratulations Andrew Wei & investigators! #ASH2019 #leusm pic.twitter.com/lPGi9QMh8E
|
||
|
||
|
Nature Rev Drug Disc
@NatRevDrugDisc
|
10. pro |
|
For those at #ASH2019, here's a recent article about the great target that BCMA seems to be: go.nature.com/38qVTpe #ASH19 pic.twitter.com/5BTcwsC5GH
|
||
|
||
|
Ajay Major, MD, MBA
@majorajay
|
10. pro |
|
Also, don't forget to check out the @symplur statistics for #ASH19.
I made the top 10 most prolific tweeters list! #ASH2019
cc @ASH_hematology @VincentRK @ninashah33 @BldCancerDoc @feldstej @hemedoc @DrRaulCordoba @DrAlexisTalbot @pembeoltulu @mabeky @mtmdphd @doctorpemm pic.twitter.com/NQb5rd7DGP
|
||
|
||
|
nizar jacques bahlis
@NBahlis
|
10. pro |
|
Proud to present Venetoclax, Dara and Dex data @#ASH2019 in t(11;14) MM, 96% VGPR or better. Precision medicine @ it’s best! pic.twitter.com/Wx8asGJbwp
|
||
|
||
|
Eric Tseng
@tsengeric
|
9. pro |
|
Cool study demonstrates that patients with discordant aPTT and heparin anti-Xa levels tend to have poorer outcomes with increased mortality risk
Hard to know if this is because discordance is marker of illness or if leads to mgmt decisions that influence outcomes
#ASH2019 pic.twitter.com/RJ1dOAWmSz
|
||
|
||
|
إبْرَاهِيْم المحْمَادِي I. Almahmadi
@mahmadi_i
|
9. pro |
|
Erythroferrone is a new hormone that is involved in Iron Deficiency Anemia.
It is encoded by ERFE Gene by Erythroblasts in the bone marrow and inhibits Hepcidin in response to ID.
Inhibition of Hepcidin leads to more Iron Absorption and more Hemoglobin synthesis.
#ASH2019 pic.twitter.com/KDMBC5q3aF
|
||
|
||
|
Jennifer Trowbridge
@TrowbridgeLab
|
9. pro |
|
Kira Young from our lab giving a fantastic presentation on the aging bone marrow microenvironment and IGF1. Our final presentation at #ASH2019 and I could not be prouder of my trainees. We will take home new ideas, collaborations and inspiration to keep pushing forward! pic.twitter.com/zZxBz210Hm
|
||
|
||
|
Anirban Sen Gupta
@JishnuSenGupta
|
9. pro |
|
Amazing days at #ASH2019 catching up with friends and collaborators, presenting on our ‘synthetic platelet’ research, building new collaborations and of course partaking in the usual shenanigans. @Clot1 @theclotthickens @MarvNieman @DrKlotter pic.twitter.com/JEAtgjhX86
|
||
|
||